Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults: The Bogalusa Heart Study

Circulation

Volumn 93, Issue 1, 1996, Pages 54-59

  Bao, Weihang ^a   Srinivasan, Sathanur R ^a   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

Author keywords

follow up studies; insulin; risk factors

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CORONARY RISK; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

EID: 0030027671     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.1.54     Document Type: Article

References (41)

1. Stout RW. Insulin and atheroma: 20-year perspective. Diabetes Care. 1990;13:631-654.
2. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
3. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980;19:205-210.
4. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9-1/2 year follow-up of the Helsinki Policeman Study population. Acta Med Scand Suppl. 1985; 701:38-52.
5. Jiang X, Srinivasan SR, Bao W, Berenson GS. Association of fasting insulin with blood pressure in young individuals: the Bogalusa Heart Study. Arch Intern Med. 1993;153:323-328.
6. Manolio TA, Savage PJ, Burke GJ, Liu KA, Wagenknecht LE, Sidney S. Association of fasting insulin and blood pressure and lipids in young adults: the CARDIA adults. Arteriosclerosis. 1990; 10:430-436.
7. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL. Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol. 1983;118:326-337.
8. Modan M, Halkin H, Fuchs Z, Lusky A, Chetrit A, Eshkol A, Segal P, Almog S, Shefi M. Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest. 1985;75: 809-817.
9. Reaven GM. Role of insulin resistance in human disease: Banting Lecture 1988. Diabetes. 1988;37:1595-1607.
10. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
11. Haffner SM, Valdez RZ, Hazuda HP, Mitchess BD, Morales PA, Stern MP. Prospective analyses of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41:716-722.
12. Burke GL, Webber LS, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism. 1986;35:441-446.
13. Rönnemaa T, Knip M, Lautala P, Viikari J, Uhari M, Leino A, Kaprio EA, Salo MK, Dahl M, Nuutinen EM, Pesonen E, Pietikäien M, Akerblom HK. Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Ann Med. 1991;23:67-72.
14. Bao W, Srinivasan SR, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: the Bogalusa Heart Study. Arch Intern Med. 1994; 154:1842-1847.
15. Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR, Frank GC, Foster TA, Blonde CV. Cardiovascular Risk Factors in Children: The Early Natural History of Atherosclerosis and Essential Hypertension. New York, NY: Oxford University Press; 1980.
16. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20: 470-475.
17. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476. Abstract.
18. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In: Lewis LA, ed. CRC Handbook of Electrophoresis. Vol. III. Lipoprotein Methodology and Human Studies. Boca Raton, Fla: CRC Press; 1983:185-204.
19. SAS Institute Inc. SAS/STAT User's Guide, Version 6, Fourth Edition. Cary, NC: SAS Institute Inc; 1989.
20. 2) and triceps skinfold thickness. Am J Clin Nutr. 1991;53:839-846.
21. Himes JH, Dietz WH. Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. Am J Clin Nutr. 1994;59:307-316.
22. Summary of the Second Report of the National Cholesterol Education Program (NCE) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
23. Freedman DS, Srinivasan SR, Burke GL, Smoak CG, Shear CL, Harsha DW, Webber LS, Berenson GS. Relation of body fat distribution to hyperinsulinemia in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr. 1987;46:403-410.
24. Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis. 1986;6:123-130.
25. Kissebah AH, Vydelingam N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982; 56:254-260.
26. Garcia-Webb P, Bonser A, Wearne KL, Gracey M. Obesity and insulin secretion in fasting high school students. Diabetologia. 1980; 19:194-197.
27. Voors AW, Harsha DW, Webber LS, Radhakrishnamurthy B. Clustering of anthropometric parameters, glucose tolerance, and serum lipids in children with high and low β- and pre-β-lipoproteins: Bogalusa Heart Study. Arteriosclerosis. 1982;2:346-355.
28. Mitchell BD, Haffner SM, Hazuda HP, Valdez R, Stern MP. The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol. 1992;136: 12-22.
29. Flack JM, Liu K, Savage P, Jacobs DR Jr, Nelson E, Gardin J, Folsom AR, Sidney S. Baseline fasting insulin predicts 2 year blood pressure change in young adults: the CARDIA Study. Circulation. 1991;83:724. Abstract.
30. Jiang X, Srinivasan SR, Bao W, Berenson GS. Association of fasting insulin with longitudinal changes in blood pressure in children and adolescents: the Bogalusa Heart Study. Am J Hypertens. 1993;6:564-569.
31. Weinsier RL, Norris DJ, Birch R, Bernstein RS, Pi-Sunyer FX, Yang MU, Wang J, Pierson RN Jr, Van Itallie TB. Serum insulin and blood pressure in an obese population. Int J Obes. 1986;10: 11-17.
32. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Lucketti L, Buonanno G, Bonati PA, Bergonzani M, Grundi L, Passeri M. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989;320: 702-706.
33. Jiang X, Srinivasan SR, Webber LS, Wattigney WA, Berenson GS. Association of fasting insulin with serum lipids and lipoproteins in children, adolescents and young adults: the Bogalusa Heart Study. Arch Intern Med. In press.
34. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893-2898.
35. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol. 1990; 131:443-453.
36. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med. 1984;76:4-12.
37. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149:1514-1520.
38. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E. Hyperinsulinaemia as a predictor of coronary artery disease mortality in a healthy population: the Paris Prospective Study, 15 year follow-up. Diabetologia. 1991;34:356-361.
39. Cullen K, Stenhouse NS, Wearne KL, Welborn TA. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13 year study. J Chron Dis. 1983;36:371-377.
40. Jarrett RJ. Why is insulin not a risk factor for coronary heart disease? Diabetologia. 1994;37:945-947.
41. Stern MP. The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia. 1994;37:956-958.